Gene tester Invitae has been clear about the company’s ambitions to make genetic information a standard part of medical practice at all stages of patient care. The San Francisco company is now aiming to offer genetic testing at the earliest stages of life by acquiring two companies that specialize in screening prospective parents and newborns. […]
NYS Entity Status
NYS Filing Date
APRIL 18, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION
2014 - DIAGNOSTIC AND INTERVENTIONAL MEDICAL CARE P.C.
Around the Web
- Invitae Expands Gene Test Menu With Good Start, CombiMatrix Deals
By Frank Vinluan - Monday Jul 31, 2017
- 3 Ways VR Is Transforming Medical Care
By Sarah DiGiulio - Tuesday Aug 22, 2017
Doctors are using VR to address some of the most challenging medical problems.
- Neighborhood Demographics and Cardiac Arrest Treatments and Outcomes
Tuesday Oct 3, 2017
Each month we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing updates in the fields of medicine and healthcare.
- Boston Tech Watch: Rethink Robotics, SquadLocker, Semcasting & More
By Jeff Engel - Friday Aug 25, 2017
There was a flurry of tech deals announced this week in Boston, including the acquisitions of Applause, Digital Lumens, and Dragon Innovation, and a $6 million investment in GNS Healthcare. Here are a few more deals you might have missed: —Rethink Robotics raised $18 million from investors, part of a funding round announced last December […]
- Investors bet big on AI for health diagnostics
By Jonathan Norris, Silicon Valley Bank - Saturday Aug 5, 2017
GUEST: We’re seeing a new wave of venture investments in healthtech companies — especially those with strong artifical intelligence and machine learning components. Led by some of the world’s largest biopharma companies and tech-focused venture capitalists, these investments are backing efforts to speed drug discovery, improve tests and treatments, and further medical research. For now, most […]